Eintrag weiter verarbeiten
Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival
Gespeichert in:
| Zeitschriftentitel: | Cancer Epidemiology, Biomarkers & Prevention |
|---|---|
| Personen und Körperschaften: | , , , , , , |
| In: | Cancer Epidemiology, Biomarkers & Prevention, 27, 2018, 3, S. 345-347 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Association for Cancer Research (AACR)
|
| Schlagwörter: |
| Zusammenfassung: | <jats:title>Abstract</jats:title> <jats:p>Background: Financial hardship is a growing challenge for patients with blood cancer who undergo hematopoietic cell transplantation (HCT), and it is associated with poor patient-reported outcomes. In contrast, little is known about the potential impact of patient-reported financial hardship on post-HCT survival.</jats:p> <jats:p>Methods: We sought to describe the association of financial hardship with survival after HCT in a prospectively assembled cohort of patients from three large transplant centers (n = 325).</jats:p> <jats:p>Results: There was no association between financial hardship measures assessed at 6 months post-HCT and 1- or 2-year survival after HCT.</jats:p> <jats:p>Conclusions: Patient-reported financial distress after HCT does not seem to adversely affect post-HCT survival.</jats:p> <jats:p>Impact: When assessing the effectiveness of interventions to ameliorate familial financial burden among HCT, the focus should be on patient-reported outcomes rather than survival. Cancer Epidemiol Biomarkers Prev; 27(3); 345–7. ©2018 AACR.</jats:p> |
|---|---|
| Umfang: | 345-347 |
| ISSN: |
1538-7755
1055-9965 |
| DOI: | 10.1158/1055-9965.epi-17-1040 |